CA2580117A1 - Coating composition - Google Patents

Coating composition Download PDF

Info

Publication number
CA2580117A1
CA2580117A1 CA002580117A CA2580117A CA2580117A1 CA 2580117 A1 CA2580117 A1 CA 2580117A1 CA 002580117 A CA002580117 A CA 002580117A CA 2580117 A CA2580117 A CA 2580117A CA 2580117 A1 CA2580117 A1 CA 2580117A1
Authority
CA
Canada
Prior art keywords
composition
coating
coat
sugar
microcrystalline cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002580117A
Other languages
French (fr)
Inventor
Michael Augello
Sharon Ray
Jian-Xin Li
Brian Carlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FMC Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2580117A1 publication Critical patent/CA2580117A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716Glucans
    • A61K31/717Celluloses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/282Organic compounds, e.g. fats
    • A61K9/2826Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Cosmetics (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The present invention is directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose present in an amount equal to greater than 41% of the total weight of the composition. The present invention is also directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose having an average particle size equal to or less than 20 microns and present in an amount equal to or greater than 20% of the total weight of the composition. The compositions of the present invention are useful in coating a wide variety of solid forms such as pharmaceutical dosage forms, veterinary dosage forms, nutraceutical dosage forms, food, industrial material, cosmetic material or oral care material. The compositions of the invention are also useful as films such as cast films. The present invention is also directed to methods of making such compositions, as well as methods of coating such compositions on solid forms.

Description

COATING COMPOSITION

This application claims the benefit of U.S. Provisional Application No.
60/612,350, filed September 23, 2004.

FIELD OF THE INVENTION

The present invention is directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose present in an amount equal to greater than 41% of the total weight of the composition. The present invention is also directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose having an average particle size equal to or less than 20 microns and present in an amount equal to greater than 20% of the total weight of the composition. The compositions of the present invention are useful in coating a wide variety of solid forms such as pharmaceutical dosage forms, veterinary dosage forms, nutraceutical dosage forms, food, industrial material, cosmetic material or oral care material. The compositions of the invention are also useful as films such as cast films. The present invention is also directed to methods of making such compositions, as well as methods of coating such compositions on solid forms.

BACKGROUND OF THE INVENTION

Sugar coatings have long been used on pharmaceutical dosage forms and on foods. In coating pharmaceutical dosage forms, such sugar coatings have often involved a complicated and lengthy process involving a number other coatings and significant drying times.

U.S. Patent No. 5,547,948 discloses the use of microcrystalline cellulose/sugar coatings can control the release rate of hormonal steroids when the microcrystalline cellulose is used at very low levels; i.e., 0.1 to 3 and further discloses the use of microcrystalline cellulose/sugar coatings where the microcrystalline cellulose is present in an amount of 7.5 to about 15%.

JPA-38[1963]-7037 discloses a mixture of microcrystalline cellulose and sugar wherein the microcrystalline cellulose has a particle size diameter no larger than 50 microns and is present in and 0.5 to 40 wt%.

SUMMARY OF THE INVENTION

The present invention is directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose present in an amount equal to greater than 41% of the total weight of the composition. The present invention is also directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose having an average particle size equal to or less than 20 microns and present in an amount equal to or greater than 20% of the total weight of the composition. The compositions of the present invention are useful in coating a wide variety of solid forms such as pharmaceutical dosage forms, veterinary dosage forms, nutraceutical dosage forms, food, industrial material, cosmetic material or oral care material. The compositions of the invention are also useful as films such as cast films. The present invention is also directed to methods of making such compositions, as well as methods of coating such compositions on solid forms.

9.

DETAILED DESCRIPTION OF THE INVENTION

In a first embodiment, the present invention is directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose present in an amount equal to greater than 41% of the total weight of the composition.

The amount of microcrystalline cellulose present in the first embodiment may also include an amount greater than 45%, 50%, 55%. Typical examples of microcrystalline cellulose that may be used in the first embodiment include Avicel PH 101 having an average particle size less equal to or less than 50 microns and Avicel PH 105 having an average particle size less than 20 microns - all of which are on sale by FMC Corporation.

A film may be prepared from the composition of the first embodiment such as a cast film, and such films may contain a wide variety of materials such as pharmaceutical and nutraceutical actives, foods, cosmetics, industrial materials, oral care materials, etc.

In a second embodiment, the present invention is directed to compositions containing: (i) sugar and/or a sugar substitute and (ii) microcrystalline cellulose having an average particle size equal to or less than 20 microns and present in an amount equal to or greater than 20% of the total weight of the composition.

The amount of microcrystalline cellulose present in the second embodiment may also include an amount greater than 30%, 40%, 45%, 50%, 55%. Typical examples of the sugar or sugar substitute include those set forth above. A
typical example of the microcrystalline cellulose that may be used in the second embodiment would be Avicel PH 105 having an average particle size less than microns.

The compositions of the first and second embodiments may consist only of the microcrystalline cellulose and sugar components, but they may also further contain water or other additives such as flavorants, colorants, plasticizers, surfactants and fillers, as well as pharmaceutical and nutraceutical actives, foods, cosmetics, industrial materials, oral care materials, etc.

The compositions of the present invention are useful in coating a wide variety of solid forms such as pharmaceutical dosage forms, veterinary dosage forms, nutraceutical dosage forms, confectionary, food, industrial material, cosmetic material or oral care material, agriculturals.

The compositions of the first and second embodiments are also useful as films such as cast films.

The compositions of the first and second embodiments may be prepared as illustrated in the examples below.

The compositions of the first and second embodiments may be coated on solid forms using conventional techniques such as spray coating. Examples of such processes are set forth below in the examples. The coatings of the inventions can be applied using a process that enables the use of spray coating in place of existing commercial techniques using non-perforated pans and significantly reduces processing time over conventionally used sugar coating processes. For example, solid forms can be coated in less than 8 hours. Typical solids for the first and second compositions when placed in suspensions are 20-75 wt% based on total weight of the suspension, more particularly, 30-50 wt%, more particularly, 40wt%.

The present invention is also directed to solid forms comprising a coating layer thereon wherein the coating layer comprises the compositions of the first or second embodiments and, optionally, one or more coating layers (such as a seal coat) between the solid form and the coating composition of the first and second embodiment. There may further be at least one coating layer applied on top of the coating composition of the first or second embodiment (such as a top coat or smooth coat).

For example, the solid forms may be coated with only with the coating composition of the first or second embodiment. The solid form may also contain a seal coat, a sugar/microcrystalline cellulose coat and optionally a smooth coating and/or a wax coating. The seal coat can be microcrystalline cellulose/carrageenan based coatings such as those described in US 6,432,448, US 6,500,462, and US
6,699,315 - all of which are incorporated herein by reference. The seal coat and the sugar/MCC coat of the first and second embodiments can be clear or colored as desired.

The seal coat when used may be applied onto the core of the solid form, generally followed by the sugar/MCC coat of the first and second embodiments, though it is possible that there can be another layer or layers of coatings between the seal coat and the sugar/MCC coat of the first and second embodiments.

Optionally, a smooth coat and/or a wax coat is applied after the sugar/MCC
coat of the first and second embodiments is applied, though it is possible that another layer can be between the sugar/MCC coat of the first and second embodiments and the smooth coat or the wax coat. The smooth coating and wax coating can be clear or colored. The smooth coating can be the same composition as the seal coat or different. The wax coating can be any standard polishing and/or waxing agent; e.g., camauba wax, polyethylene glycol (polisher) and propylene glycol (polisher).

Typical commercial pharmaceutical processes involving sugar based coatings require considerable time because of various coating steps thought to be required or desired. A typical coating time involving a sugar coating could be days depending on batch size. The present invention as mentioned above allows the manufacture of solid dosage forms having a sugar coating in significantly less time;
e.g., 1.5 hours to 8 hours depending on batch size. It also provides coating compositions having desirable physical attributes and, in some cases, highly preferred elegant (smooth) coatings.

The present invention is now described in more detail by reference to the following examples, but it should be understood that the invention is not construed as being limited thereto. Unless otherwise indicated herein, all parts, percents, ratios and the like are by weight.

EXAMPLES
MANUFACTURING PROCEDURE

Examples 1-14 below used the following experimental protocol.

The seal coating composition was prepared by first premixing the powder ingredients in a blender and then slowly adding the powder premix to deionized water under good agitation. The coating was stirred for 1 hour.

The sugar/MCC coating was prepared by slowly adding a dry premix of the microcrystalline cellulose and granulated sugar (sucrose) to deionized water to form suspension. In Examples 1-3 below, the deionized water was not heated, but the deionized water was first heated to 60 C for more rapid sugar dissolution in Examples 4-10.

The smooth coating composition may be either a clear or colored coating composition. Colored smooth coating compositions were prepared by first preparing the clear coating then adding liquid colorant. Witll carrageenan-based smooth coatings, the dry powder premix was added to the deionized water, then mixed for 15 minutes prior to addition of the colorant, followed by mixing for an additional 45 minutes. The alternate sucrose color smooth coating was prepared by mixing colorant into a 70% sucrose suspension.

Coatings were applied to a 1.5 kilogram charge of ibuprofen 200 mg tablet cores in 15 inch pan using an Accela Cota "Comp-U-Coat" with #4 Baffles. The spray apparatus included #1 Binks Guns (2.01nm Fluid Nozzle), 40100 Air Cap, having a coating delivery system of a Model Digital Console Drive #7523-50 containing Masterflex Pump #1 Pump Head, #24 Tubing, 94600. Specific coating parameters for inlet air temperature, exhaust air temperature, air flow, gun atomization pressure, pan speed, coating delivery rate and coating time are presented within the examples. In general, the pan speed and spray rate were initially low to avoid overwetting of the tablets and increased to the maximum pan speed and spray rate after approximately 0.25 weight % to 0.5 weight % of coating by total weight of the suspension was applied.

CA 02580117 2007-03-09 , When the tablets were waxed and polished, the tablet bed was heated to approximately 100 C, the inlet and exhaust was shut off and about 1 to 2 wt%
of camauba wax by total weight of the tablet was added and the bed was allowed to roll for 1 to 2 minutes. The exhaust was turned on to remove any excess and the tablets were allowed to roll for about 5 minutes while cooling to room temperature.
Testing procedures Viscosity was measured with a Brookfield RVT using a #4 spindle at 20 rpm after 20 seconds. Hardness was measured using a Schleuniger tester.
Disintegration was measured using USP standards. Friability was measured according to USP

standards with the friability time as indicated. Dissolution was measured according to USP standards for ibuprofen - apparatus was 2 (paddle, 50 rpm, 900 ml, 0.05M
phosphate buffer, pH 7.2).

A 10% solids seal coating composition having a viscosity of 1500 mPa-s was prepared using a powder premix of 44 % Avicel PH-105, 18% of cold-soluble iota carrageenan (visc = 600cps) and 38% of PEG 8000. A sugar build up suspension was prepared using a powder premix of 70% granulated sugar and 30% Avicel PH-105 and cold deionized water. Tablets were coated sequentially to give seal coat (3% weight gain of the tablet) and a sugar/microcrystalline cellulose layer (30 to 40% weight gain of the tablet).

Table 1: Coating Parameters Seal Coat Sugar/MCC
Inlet Air Temperature, C 50-65 50-55 Exhaust Air Temperature, C 31-45 35-41 Air, CFM 250-259 200-210 ATM, psi 25 25 Pan Speed, RPM 10-14 15-18 Delivery Rate, gms/min 17-72 16-20 Coating Time, minutes 60.0 40.0 Table 2: Physical Testing 24-Hrs Out of Pan Uncoated Cores Tablet Weight, grams 6.137 4.06 Thickness, mm 7.82 6.40 Hardness, Kp 10.7 3.2 Disintegration 37 C DI Water) 7.30 0.5 Friability (5.0 minutes), % 0 0.143 Table 3 Dissolution Profile Time 24-Hrs Out of Pan Uncoated Cores minutes 96 3.0 97 2.4 30 minutes 99 2.1 99 1,7 45 minutes 99 1.9 99 2.0 60 minutes 100 2.1 100 1.6 Tablets were coated with the compositions of example 1 to give a three layer coated tablet. After the seal coating (3% weight gain) and the sugar/MCC
coating 10 (30-40% weight gain), tablets batches were coated with a smooth coat layer of 1%

and 2% by weight of the total tablet weight. The clear smooth coat composition was the same as the seal coat composition of Example 1.

Table 4: Coating Parameters Seal Coat Sugar/MCC coat Smooth Coat Inlet Air Temperature, C 55 55-60 55 Exhaust Air Temperature, C 34.3-42.7 39.7-47.5 37.3-41.6 Air, CFM 250-259 225-233 250-258 ATM, psi 25 25 25 Pan Speed, RPM 12 12 12 Delivery Rate, gms/min 15-25 10-15 15 Coating Time, minutes 22 47 1%-- 10 2%--22 Table 5: Physical Testing 24 Hours Out of Pan 1% Smooth 2% Smooth Uncoated Coat Coat Tablets Tablet Weight, grams 5.76 5.94 4.06 Thickness, mm 7.49 7.54 6.40 Hardness, Kp 9.9 10.2 3.2 Disintegration (37 C DI 2.36 2.72 0.5 Water) Friability (5.0 minutes ,% 0 0 0.143 Tablets were coated with the compositions of Example 1 to give a three layer coated tablet with varied thickness of seal coat and sugar/MCC layers. After the seal coating (5% weight gain of the tablet) and the sugar/MCC coating (20-40%
weight gain of the tablet), tablet batches were coated either with a smooth coat layer of 1%

or 2% by weight of the tablet weight. The clear smooth coat composition was the same as the seal coat composition of Example 1.

Table 6: Coating Parameters Seal Coat Sugar/MCC coat Smooth Coat Inlet Air Temperature, C 50-55 50-55 50 Exhaust Air Temperature, C 38-40 38-40 39-40 Air, CFM 250-261 253-267 250-263 ATM, psi 25 25 25 Pan Speed, RPM 10.8 12-18 10-8 Delivery Rate, gms/min 15-25 15-20 15 Coating Time, minutes 35 35 1%--12 2%--24 Table 7: Physical Testing 24 Hours Out of Pan 1% 2% Uncoated Smooth Coat Smooth Coat Tablets Tablet Weight, grams 5.29 5.39 4.06 Thickness, mm 7.13 7.18 6.40 Hardness, Kp 9.2 9.9 3.2 Disintegration (37 C DI 2.22 3.0 0.5 Water) Friability (5.0 minutes ,% 0 0 0.143 Table 8: Dissolution Profile Time 1% 2%
Smooth Coat Smooth Coat Uncoated Cores 15 minutes 98 1.6 96 1.2 97 2.4 30 minutes 99 1.4 99 1.1 99 1,7 45 minutes 100 1.5 100 0.6 99 2.0 60 minutes - - 100 1.6 Tablets were coated with the compositions of Example 1 to give a three layer coated tablet with varied thickness of seal coat and sugar/MCC layers. After the seal coating (3% weight gain) and the sugar/MCC coating (30-40% weight gain), tablet batches were coated either with a smooth coat layer of 1% or 2% by weight of the total tablet weight. The clear smooth coat composition was the same as the seal coat composition of Example 1. Dissolution performance was compared to commercial ADVIL caplets.

Table 9: Coating Parameters Seal Coat Sugar/MCC coat Smooth Coat Inlet Air Temperature, C 55-57 57-60 55 Exhaust Air Temperature, C 37.3-42.7 41.3-47.7 38.9-41.9 Air, CFM 250-256 219-230 250-253 ATM, psi 25 25 25 Pan Speed, RPM 12 12 12 Delivery Rate, gms/min 15-27 15-17 15 Coating Time, minutes 21 45 1%-- 10 2%--21 Table 10: Physical Testing 24 Hours Out of Pan 1% 2% Uncoated Tablets Smooth Coat Smooth Coat Tablet Weight, grams 5.852 5.79 4.06 Thickness, mm 7.52 7.50 6.40 Hardness, Kp 9.2 10.0 3.2 Disintegration (37 C DI 2.35 2.88 0.5 Water) Friability (5.0 minutes ,% 0 0 0.143 Table 11: Dissolution Profile Time 1% 2% Advil Uncoated Smooth Coat Smooth Coat Tablets 15 minutes 96 2.0 99 1.2 97 4.0 97 2.4 30 minutes 98 1.4 100 1.0 99 3.6 99 1,7 45 minutes 99 1.3 100 3.0 99 2.0 60 minutes 99 1.5 100 1.6 Tablets were coated with the compositions of Example 1 to give a three layer coated tablet with varied thickness of seal coat and sugar/MCC layers. After the seal coating (3% weight gain) and the sugar/MCC coating (30-40% weight gain), tablet batches were coated either with a colored smooth coat layer of 1% or 2% by weight of the total table weight. The blue smooth coat composition was prepared at 10%
total solids using a 3 to 1 weight ratio of the premix solids composition of the seal coat in Example 1 to the pigment solids. The aqueous pigment dispersion used was Chroma Kote blue with 24% pigment loading (Chris Hansen) Table 12: Coating Parameters Sugar/MCC Blue Smooth Coat Seal Coat coat (3:1 premix solids: i ment Inlet Air Temperature, C 65-66 50-65 55-60 Exhaust Air Temperature, C 37-43 42.3-46.2 39.3-43.5 Air, CFM 248-256 217-238 247-263 ATM, psi 25 25 25 Pan Speed, RPM 12 12 12 Delivery Rate, gms/min 20-45 10-15 15-32 Coating Time, minutes 14 60 1%-- 7 2%--12 Table 13: Physical Testing 24 Hours Out of Pan 1% Blue 2% Blue Uncoated Smooth Coat Smooth Coat Tablets Tablet Weight, grams 5.91 6.22 4.06 Thickness, mm 7.46 7.61 6.40 Hardness, Kp 11.4 10.2 3.2 Disintegration (37 C DI Water), 2.44 3.31 0.5 min Friability, % (5.0 minutes) NT NT 0.143 (30 minutes) 0 0 NT

Tablets were coated with the compositions of Example 1 to give a three layer coated tablet with varied thickness of seal coat and sugar/MCC layers. After the seal coating (3% weight gain) and the sugar/MCC coating (30-40% weight gain) were applied, tablet batches were coated either with a colored smooth coat layer of 1% or 2% by weight of the total tablet weight. The blue smooth coat composition was prepared at 10% total solids using the 10 to 1 weight ratio of the premix composition of the clear seal coat in Example 1 to the pigment solids. The aqueous pigment dispersion used was Chroma Kote blue with 11 % pigment loading (Chris Hansen).

Table 14: Coating Parameters Seal Coat Sugar/MCC Blue Smooth coat coat 10:1 prem i ment Inlet Air Temperature, C 55-60 60 60 Exhaust Air Temperature, 37-43 42-43 42-48 c Air, CFM 250-258 225-233 250-259 ATM, psi 25 25 25 Pan Speed, RPM 12 12 13 Delivery Rate, gms/min 15-30 15-17 15-25 Coating Time, minutes 18 47 1%-- 12 2%--22 Table 15: Physical Testing 0 2% Uncoated 24 Hrs Out of Pan Smoo ho coat Smooth Tablets Coat Tablet Weight, grams 6.045 6.04 4.06 Thickness, mm 7.56 7.54 6.40 Hardness, Kp 12.9 12.5 3.2 Disintegration (37 C DI Water), 3.11 4.68 0.5 min Friability, % (5.0 minutes) NT NT 0.143 (30 minutes) 0.06 0 NT

Coated tablets were prepared as in Example 5. Coated tablets were waxed and polished using 1-weight % carnauba wax.

Table 16: Coating Parameters Seal Coat Sugar/MCC Smooth coat 10:1 remix/ i ment Inlet Air Temperature, C 55-60 60 60 Exhaust Air Temperature, 38-44 45-58 45-47 C
Air, CFM 250-258 208-220 250-259 ATM, psi 25 25 25 Pan Speed, RPM 12-13 14 13 Delivery Rate, gms/min 15-30 15-17 15-25 Coating Time, minutes 17 47 1%-- 10 2%--12 Table 17: Physical Testing 24 Hours Out of Pan 1% 2%
Smooth Coat Smooth Coat Tablet Weight, grams NT 5.93 Thickness, mm NT 7.42 Hardness, Kp NT 10.2 Disintegration (37 C DI Water), NT 3 min Friability, (30 minutes ,% NT 0 A 9% solids aqueous seal coating composition was prepared using a powder premix of 75 % Avicel PH-105, 25% of cold-soluble iota carrageenan (visc = 225 cps). The seal coat viscosity was 900 mPas. The sugar/MCC coating was prepared by using a powder premix of 70% granulated sugar and 30% Avicel PH-105 by dissolving in hot (60 C) deionized water to form a suspension. A 9% solids smooth coat composition was prepared using a 10 to 1 weight ratio of the powder premix coinposition used in the seal coat to pigment solids. The piginent used was Opalux brown liquid (Colorcon). The smooth coat viscosity was 800 mpas. Tablets were coated sequentially to give seal coat (3% weight gain) and a sugar/microcrystalline cellulose layer (30 to 40% weight gain) and a smooth coat (2%). Tablets were also prepared with the saine coating layers that were then waxed and polished.

Table 18: Coating Parameters Seal Coat Suage/MCC coat Smooth Coat Inlet Air Temperature, C 55-60 60 60 Exhaust Air Temperature, C 38.5-42.8 43.8-47.3 25.0-25.9 Air, CFM 255-259 209-238 250-259 ATM, psi 25 25 25 Pan Speed, RPM 11 12 11 Delivery Rate, gms/min 20-40 8-10 20-30 Coating Time, minutes 23 67 18 Table 19: Physical Testing 24 Hours Out of Pan 2% Uncoated Tablets Smooth Coat Tablet Weight, grams 4.78 3.07 Thickness, mm 6.27 6.13 Hardness, Kp 19.6 10.8 Disintegration (37 C DI Water), min 3 0.44 Friability, (30 minutes ,% 0 0 A 15% solids aqueous seal coating composition (spray dried) was prepared using a powder premix of 58 % Avicel PH-105, 11% of cold-soluble iota carrageenan (viscosity = 275 cps) and 31% glycerin. The seal coat viscosity was 600 mPas. The sugar/MCC coating was prepared using a powder premix of 70%
granulated sugar and 30% Avicel PH-105 by dissolving in hot (60 C) deionized water to form a suspension. The smooth composition was the same as the seal coat composition. Tablets were coated sequentially to give seal coat (3% weight gain) and a sugar/microcrystalline cellulose layer (30 to 40% weight gain) and a smooth coat (1% or 2%, respectively).

Table 20: Coating Parameters Seal Coat Sugar/MCC Smooth Coat Inlet Air Temperature, C 55 60 60 Exhaust Air Temperature, C 38.6-39.6 44.3-47.5 45.7-46.9 Air, CFM 250 216-224 250-258 ATM, psi 25 25 25 Pan Speed, RPM 12 12 12 Delivery Rate, gms/min 15-20 14 15-25 Coating Time, minutes 18 48 1%-- 8 2%--16 Table 21: Physical Testing 24 Hours Out of Pan 1% 2% Uncoated Tablets Smooth Coat Smooth Coat Tablet Weight, grams 4.68 4.61 3.27 Thickness, mm 6.30 6.31 5.34 Hardness, Kp 17.6 18.4 10.8 Disintegration (37 C Di Water), min NT NT > 30 Friabilit ,% (30 minutes) 0 0 1.87 The seal coat and sugar/MCC compositions of Example 9 were used. A
smooth coat composition was prepared using a 10 to 1 weight ratio of the powder premix composition used in the seal coat to pigment solids. The pigment used was Opalux brown liquid (Colorcon). Tablets were coated sequentially to give seal coat (3% weight gain) and a sugar/microcrystalline cellulose layer (30 to 40%

weight gain) and a smooth coat (2% weight gain). Tablets were also prepared with the same coating layers then were waxed and polished.

Table 22: Coating Parameters Seal Coat Sugar/MCC Smooth Coat 10:1 remix/ i ment Inlet Air Temperature, C 55 60 60 Exhaust Air Temperature, 38.6-39.6 44.3-47.5 45.7-46.9 c Air, CFM 250 216-224 250-258 ATM, psi 25 25 25 Pan Speed, RPM 12 12 12 Delivery Rate, gms/min 15-20 14 15-25 Coating Time, minutes 18 48 1%-- 8 2%--16 Table 23: Physical Testing 2% Smooth 2% Smooth 24 Hours Out of Pan Coat with Coat with Uncoated Pigment Pigment and Tablets Wax Tablet Weight, grams 5.46 5.41 3.27 Thickness, mm 6.68 6.68 5.34 Hardness, Kp 19.8 18.9 10.8 Disintegration 37 C DI Water), min NT NT > 30 Friabilit ,% (30 minutes) 0 0 1.87 Tablets were coated with the composition of Example 1 to give a four-layer coated tablet with varied thickness of seal coat, MCC/sugar layer, smooth coat and pigmentation coat. After the seal coating (3% weight gain) and the MCC/sugar coating (25-40% weight gain), a smooth clear coat (2% weight gain) was added to the coating process to create a smooth surface before the pigmentation coat was added. The red pigment coating composition was prepared at 10% total solids, using a 10:1 weight ratio of the premix solids composition of the seal coat in Example 1 to the pigment solids. The aqueous piginent dispersion used was Opalux Brown with a 13-15% pigment loading (Colorcon).

Coating Parameters Seal Coat Sugar/MCC Coat Smooth Coat Pigment Coat Inlet Air Temp, C 70 86.0-86.2 69.5-69.9 69.9-70 Exhaust Air Temp, C 38-40 46.0-47.0 37.7-38.0 38-39 Air, CFM 36-39 36-39 36-38 36-38 ATM, PSI 25.0 25.0 25.0 25.0 Pan Speed, RPM 15.0 15.0 12.0 12.0 Delivery Rate, g/min 11.25 11.5 20.0 11.7 Coating Time, min 40.0 65.0 20.0 35.0 24 hours Out of Pan - Physical Testing Tablet Weight, gms 4.59 Thickness, mm 6.285 Hardness, kp 12.23 Disintegration, min 6-9 (DI Water) Friability, % 30 minutes - 0%
Dissolution Profile 99 0.8 30 99 0.8 45 100 0.8 Tablets were coated with the composition of Example 1 to give a four-layer coated tablet with varied thickness of seal coat and sugar/MCC layers. After the seal coating (2% weight gain) and the sugar/MCC coating (25-35% weight gain), tablets were then coated with a clear smooth coat layer of 2% by weight of the total tablet weight. The clear smooth coat composition was the same as the seal coat composition of Example 1. The fourth layer of coating was applied using a pigmented dispersion (Opalux Brown liquid) with a 5.0% pigment loading (Colorcon).

Coating Parameters Seal Coat Sugar/MCC Coat Smooth Coat Pigment Coat Inlet Air Temp, C 55-57 55-57.3 55 55-67 Exhaust Air Temp, C 38-40 38.40-46.3 40-42 38-43 Air, CFM 225 219-226 250-251 250-ATM, PSI 25.0 25.0 25.0 25.0 Pan Speed, RPM 12.0 12.0 12.0 11-13 Delivery Rate, g/min 11-17 8.3-21.7 17-20 25-45 Coating Time, min 22.0 59.0 27.0 29.0 A 10% solids seal coating composition, having a viscosity of 1500 mPA=s, was prepared by using a powder premix of 55% Avicel PH-105, 18% of iota carrageenan (viscosity ~ 600 cps) and 38% PEG 8000. A sugar build-up suspension was prepared using a powder premix of 55% Avicel PH-105, 45% granulated sugar, and hot deionized water (80 C), preparing a 40 % solids suspension.
Tablets were coated sequentially to give a seal coat (3% weight gain of the tablet), sugar/MCC layer (25-35% weight gain of the tablets), a clear smooth coat (same composition as the seal coat, 2% weight gain of the tablets), and a pigmented coat (3% weight gain of the tablets). A 10% solids smooth coat composition was prepared using a 10:1 weight ratio of the powder mix composition used in the seal coat to pigment solids. The pigment used was Opalux Brown liquid (Colorcon).
Coating Parameters Seal Coat Sugar/MCC Coat Smooth Coat Pigment Coat Inlet Air Temp, C 59.4-60.1 55.1-56.7 54.4-54.8 55.0-55.3 Exhaust Air Temp, C 37.6-41.8 40.4-43.9 40.2-40.4 40.2-41.4 Air, CFM 250-264 221-225 256.0 247-ATM, PSI 25.0 25.0 25.0 25.0 Pan Speed, RPM 12-22 15.5-25.6 17.0 21-35 Delivery Rate, g/min 12.0 12.0-12.5 12.5-14 12.5-14 Coating Time, min 15.0 61.0 25.0 19.0 24 hours Out of Pan - Physical Testing Tablet Weight, gms 5.62 Thickness, mm 6.18 Hardness, kp 7.8 Disintegration, min 3.75 (37 C DI Water) Friability, % 5 minutes - 0%
30 minutes - 0%
Dissolution Profile Time 24 Hours Out of Pan Uncoated Cores minutes 97 1.6 97 +2.4 30 minutes 99 0.8 99 1.7 10 45 minutes 101 1.3 99 2.0 60 minutes - 100 1.6 15 Cast films utilizing a LustreClearTM composition (e.g., MCC (44%), sodium iota carrageenan (18%), PEG (38%)) and condition under the appropriate temperature/humidity. When the films are formed, place one (1) film in an appropriate vessel. Prepare the Avicel /sucrose suspensions of the invention in accordance with the Manufacturing Procedure herein. If desired, add to the above suspension and/or LustreClearTM film medications such as antihistamines, non-steroidal anti-inflanmiatories, cardiovasculars, antihypertensives, etc. Pour the Avicel /sucrose suspensions of the invention over the cast film and, to that apply an additional LustreClearTM cast film. Place the sample in the appropriate temperature/humidity chamber and let condition. When conditioning is complete, cut the film into strips exemplifying a Fast Disintegrating Medicated Strip.

While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.

Claims (19)

1. A composition comprising: (i) at least one sugar or sugar substitute and (ii) microcrystalline cellulose, wherein said microcrystalline cellulose is present in an amount equal to greater than 41% of the total weight of the composition.
2. A composition as in claim 1, wherein said microcrystalline cellulose is present in an amount of greater than 45% of the total weight of the composition.
3. A composition as in claim 1, wherein said microcrystalline cellulose is present in an amount of greater than 50% of the total weight of the composition.
4. A composition as in claim 1, wherein said microcrystalline cellulose is present in an amount of greater than 55% of the total weight of the composition.
5. A composition as in claim 1, wherein said microcrystalline cellulose has an average particle size equal to or less than 50 microns.
6. A composition as in claim 1, wherein said microcrystalline cellulose has an average particle size equal to or less than 20 microns.
7. A solid form comprising a coating layer thereon wherein said coating layer comprises the composition of claim 1 and, optionally, one or more coating layers between the solid form and the coating composition of claim 1.
8. A solid form of claim 7 wherein said solid form is a pharmaceutical dosage form, veterinary dosage form, nutraceutical dosage form, confectionary, food, industrial material, cosmetic material or oral care material.
9. A film comprising the composition of claim 1.
10. A film as in claim 9, wherein said film is a cast film.
11. A method for coating a solid form optionally containing one or more coatings, comprising applying the composition of claim 1 directly onto the solid form or optionally onto the solid form containing one or more coatings.
12. A composition comprising: (i) at least one sugar or sugar substitute and (ii) microcrystalline cellulose, wherein said microcrystalline cellulose has an average particle size equal to or less than 20 microns and is present in an amount equal to or greater than 20% of the total weight of the composition.
13. A composition of claim 12, wherein said microcrystalline cellulose is present in an amount of equal to or greater than 30% of the total weight of the composition.
14. A composition of claim 12, wherein said microcrystalline cellulose is present in an amount of equal to or greater than 40% of the total weight of the composition.
15. A solid form comprising a coating layer thereon wherein said coating layer comprises the composition of claim 12 and, optionally, one or more coating layers between the solid form and the coating composition of claim 12.
16. A solid form of claim 15 wherein said solid form is a pharmaceutical dosage form, veterinary dosage form, nutraceutical dosage form, confectionary, food, industrial material, cosmetic material or oral care material.
17. A film comprising the composition of claim 12.
18. A film as in claim 17, wherein said film is a cast film.
19. A method for coating a solid form optionally containing one or more coatings, comprising applying the composition of claim 12 directly onto the solid form or optionally onto the solid form containing one or more coatings.
CA002580117A 2004-09-23 2005-09-22 Coating composition Abandoned CA2580117A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61235004P 2004-09-23 2004-09-23
US60/612,350 2004-09-23
PCT/US2005/033969 WO2006034397A2 (en) 2004-09-23 2005-09-22 Coating composition

Publications (1)

Publication Number Publication Date
CA2580117A1 true CA2580117A1 (en) 2006-03-30

Family

ID=36090667

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002580117A Abandoned CA2580117A1 (en) 2004-09-23 2005-09-22 Coating composition

Country Status (9)

Country Link
US (1) US20060127451A1 (en)
EP (1) EP1791527A2 (en)
JP (1) JP2008513584A (en)
CN (1) CN101027043A (en)
BR (1) BRPI0515416A (en)
CA (1) CA2580117A1 (en)
IL (1) IL181960A0 (en)
MX (1) MX2007003519A (en)
WO (1) WO2006034397A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
US8932629B2 (en) * 2006-10-27 2015-01-13 Fmc Corporation Co-processed microcrystalline cellulose and sugar alcohol as an excipient for tablet formulations
US20080131467A1 (en) * 2006-11-30 2008-06-05 Dennis Nelson Film-coated solid dosage form
US7767248B2 (en) * 2007-02-02 2010-08-03 Overly Iii Harry J Soft chew confectionary with high fiber and sugar content and method for making same
US20090011079A1 (en) * 2007-07-02 2009-01-08 Bestsweet, Inc. Hard Coated Confectionary Having A Consumable Soft Chewing Core With An Active And Method For Making Same
SG169922A1 (en) * 2009-09-24 2011-04-29 Taiwan Semiconductor Mfg Improved semiconductor sensor structures with reduced dislocation defect densities and related methods for the same
WO2013052118A1 (en) 2011-10-05 2013-04-11 Fmc Corporation Stabilizer composition of co-attrited microcrystalline cellulose and carboxymethylcellulose, method for making, and uses
JP6188030B2 (en) 2011-10-05 2017-08-30 エフ エム シー コーポレーションFmc Corporation Stabilizer composition for microcrystalline cellulose and carboxymethylcellulose, method for producing the composition, and food product
PL2787837T3 (en) 2011-12-09 2017-09-29 Fmc Corporation Co-attrited stabilizer composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL224413A (en) * 1957-01-28
JPS4837815B1 (en) * 1970-09-25 1973-11-14 Yamanouchi Pharma Co Ltd
JPS5454169A (en) * 1977-10-08 1979-04-28 Asahi Chem Ind Co Ltd Compound
JPH0770365A (en) * 1993-09-02 1995-03-14 Asahi Chem Ind Co Ltd Water-dispersible composition
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
JPH10179045A (en) * 1996-12-25 1998-07-07 Osaka Kagaku Gokin Kk Sheet-like edible molding
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
RS51561B (en) * 2000-02-29 2011-08-31 Bristol-Myers Squibb Co. Low dose entecavir formulation and use

Also Published As

Publication number Publication date
BRPI0515416A (en) 2008-07-22
US20060127451A1 (en) 2006-06-15
JP2008513584A (en) 2008-05-01
WO2006034397A3 (en) 2006-07-13
CN101027043A (en) 2007-08-29
MX2007003519A (en) 2007-08-07
IL181960A0 (en) 2007-07-04
EP1791527A2 (en) 2007-06-06
WO2006034397A2 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
US20060127451A1 (en) Coating composition
EP2961387B1 (en) Delayed release film coatings containing calcium silicate and substrates coated therewith
AU703933B2 (en) Moisture barrier film coating composition, method, and coated form
AU2005231145B8 (en) Enteric coatings for orally ingestible substrates
JP4638046B2 (en) Edible coating composition
RU2528095C2 (en) Systems of film coating for preparations with immediate release, creating enhanced anti-moisture barrier, and substrates with such coating
US6500462B1 (en) Edible MCC/PGA coating composition
JP2004508321A (en) Dry powder film coating composition and method for producing the same
JP2005526039A (en) Edible PGA coating composition
JP2004531467A (en) Edible PGA coating composition
EP1231901A1 (en) Edible coating composition
US10758489B2 (en) Acidifying coatings and disintegration-resistant substrates coated therewith
AU3808301A (en) Acrylic enteric coating compositions

Legal Events

Date Code Title Description
FZDE Discontinued